Related Experiment Video
Updated: Feb 14, 2026

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
Published on: July 31, 2021
Bordetella pertussis (Bp) disease: Before (2003-2011) and after (2013-2016) maternal immunization strategy in a
Angela Gentile1, María Del Valle Juarez1, María Florencia Lucion1
1"R. Gutiérrez" Children's Hospital, Epidemiology, 1330 Gallo St, PO 1425, Buenos Aires, Argentina.
Insights
Maternal Tdap vaccination significantly reduced infant hospitalizations and eliminated deaths from whooping cough (Bordetella pertussis). This shows the effectiveness of Tdap in pregnancy for infant protection.
Area of Science:
- Pediatrics
- Immunology
- Public Health
Background:
- Whooping cough (Bordetella pertussis) poses a significant risk of morbidity and mortality in infants under one year old.
- Argentina implemented Tdap vaccination in pregnancy in 2012 to protect infants.
Introduction:
Whooping cough continues to be a major cause of morbidity and mortality in infants younger than 1 year. In 2012, Argentina introduced Tdap in pregnancy to prevent infant mortality. The aim of this study is to describe the impact of maternal immunization on the hospitalization and mortality rates of confirmed Bordetella pertussis (Bp) cases by comparing pre- and post-Tdap vaccine recommendation periods.
Material And Methods:
All PCR-confirmed Bp cases from "R. Gutierrez" Children's Hospital identified between December 2003 and December 2016 were included in. Analysis was performed comparing hospitalization rates (per 10,000 discharges) between pre-vaccination (PreV) 2003-2011 and post-vaccination (PostV) 2013-2016 time periods, excluding the intervention year (2012).
Results:
During the study time frame, there were 1046 suspected Bp cases, of which 337 (32.2%) were confirmed. Three-hundred eight cases were analyzed (excluding year 2012): 237 in PreV and 71 in PostV. In comparison with PreV, PostV cases were older (3 vs 9 months; p < 0.001), and required less hospitalization (86.9% vs 67.6%; p < 0.001). Bp hospitalization rate (HR) decreased (22.3 vs 11.6; p < 0.001). The mortality rate in PreV 5.9% (14 cases); there were not deaths during PostV (p = 0.036).
Conclusions:
Confirmed cases were among infants younger than 1 year In PostV, Bp cases were older and there was a significant decrease in the hospitalization rate. There were no fatal cases in our center after the pregnancy Tdap recommendation was implemented.
More Related Videos
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
07:13Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C
Published on: March 25, 2016
Related Concept Videos
Hospitals-II
Nurses that work in...
Hospitals-I
What is the Immune System?
Humoral Immune Responses
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution